In today’s plenary session at #AACR26, Dr. Angela Coxon (@acoxon_coxon) of @Amgen highlighted exciting advances in next-generation T-cell engagers, showcasing innovative engineering strategies to overcome the challenges of solid tumors and expand precision immunotherapy. #AACR26 https://t.co/3rV44flzMR